查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
2112862

全球新冠病毒診斷市場規模、佔有率、趨勢和成長分析報告（2026-2034）

Global COVID-19 Diagnostic Market Size, Share, Trends & Growth Analysis Report 2026-2034
出版日期: | 出版商: Value Market Research | 英文 235 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球新冠病毒診斷市場預計將從2025年的131.2億美元成長到2034年的17.8億美元，2026年至2034年的複合年成長率（CAGR）為19.88%。疫情期間，隨著醫療系統對快速且準確的檢測方法的需求，全球新冠病毒診斷市場迅速擴張。 PCR檢測、抗原檢測和抗體檢測等診斷技術成為監測病毒傳播的重要工具。各國政府和醫療機構大力投資大規模檢測項目，大幅提升了醫院、檢查室和檢測中心對新冠病毒診斷解決方案的需求。

該市場的主要驅動力之一是對感染疾病早期可靠檢測的需求。快速診斷試劑盒和就地檢驗提高了診斷速度，使醫護人員能夠迅速應對疫情爆發。對診斷基礎設施和生物技術研究投入的增加也推動了先進檢測技術的發展。

受分子檢測平台和多疾病診斷工具的改進推動，新冠病毒診斷市場預計將進一步發展。各國政府從此次疫情中汲取的經驗教訓促使其加強診斷系統，以因應未來的疫情爆發。快速檢測和檢查室自動化領域的持續創新有望支撐全球診斷行業的持續成長。

我們的報告經過精心撰寫，旨在提供涵蓋廣泛行業和市場的全面且切實可行的洞察。每份報告都包含多個關鍵組成部分，旨在幫助您全面了解市場環境。

市場概覽：本節對市場進行了清晰的說明，包括關鍵定義、分類以及當前行業格局的概述。

市場動態：對影響市場成長的關鍵促進因素、限制因素、機會和挑戰進行詳細評估。這包括技術發展、法律規範和不斷變化的行業趨勢等因素。

市場區隔分析：本部分依據產品類型、應用、最終使用者和地區，將市場系統性地分類為若干關鍵細分市場。本部分揭示了每個細分市場的表現、成長潛力和市場貢獻。

競爭格局：我們對主要市場參與企業進行了詳細評估，包括其市場定位、產品系列、策略舉措和財務表現。本部分深入分析了競爭趨勢以及主要參與企業所採取的策略，提供了寶貴的見解。

市場預測：本部分提供以資料為基礎的市場規模和成長模式展望，預測期為指定期間。它綜合考慮歷史趨勢、當前市場狀況和定量分析，揭示未來發展趨勢。

區域分析：我們全面檢驗主要地理區域的市場趨勢，並識別高成長細分市場和區域趨勢，以更深入地了解每個區域特有的市場機會。

新趨勢與新機會：識別關鍵市場趨勢、技術進步和新的投資機會。本部分重點在於潛在的成長領域和未來產業趨勢。

客製化選項：我們提供靈活的報告客製化服務，可根據客戶需求進行調整。這包括額外的細分、國家/地區分析、競爭對手分析、客製化資料點或針對特定細分市場的洞察，以更有效地支援策略決策。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

  • 市場譜系展望
  • 滲透率和成長前景分析
  • 價值鏈分析
  • 法律規範
    • 標準與合規性
    • 監管影響分析
  • 市場動態
    • 市場促進因素
    • 市場限制因素
    • 市場機遇
    • 市場挑戰
  • 波特五力分析
  • PESTLE分析

第4章 全球新冠病毒診斷市場：依產品與服務分類

  • 市場分析、洞察與預測
  • 裝置
  • 試劑和試劑盒
  • 服務

第5章 全球新冠病毒診斷市場：依樣本類型分類

  • 市場分析、洞察與預測
  • 鼻咽拭子
  • 口腔和咽拭子
  • 鼻拭子
  • 血
  • 其他

第6章 全球新冠病毒診斷市場：依檢測類型分類

  • 市場分析、洞察與預測
  • 分子（PCR）檢測
  • 抗原檢測
  • 抗體（血清學）檢測
  • 其他

第7章 全球新冠病毒診斷市場：依模式分類

  • 市場分析、洞察與預測
  • 照護現場(PoC)
  • 非照護現場（PoC）

第8章 全球新冠病毒診斷市場：依最終用途分類

  • 市場分析、洞察與預測
  • 檢查室
  • 醫院
  • 診斷中心和診所
  • 其他

第9章 全球新冠病毒診斷市場：按地區分類

  • 區域分析
  • 北美市場分析、洞察與預測
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲市場分析、洞察與預測
    • 英國
    • 法國
    • 德國
    • 義大利
    • 俄羅斯
    • 其他歐洲國家
  • 亞太市場分析、洞察與預測
    • 印度
    • 日本
    • 韓國
    • 澳洲
    • 東南亞
    • 其他亞太國家
  • 拉丁美洲市場分析、洞察與預測
    • 巴西
    • 阿根廷
    • 秘魯
    • 智利
    • 其他拉丁美洲國家
  • 中東和非洲市場分析、洞察與預測
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 南非
    • 其他中東和非洲國家

第10章 競爭格局

  • 最新趨勢
  • 公司分類
  • 供應鏈和分銷通路合作夥伴（根據現有資訊）
  • 市場佔有率和市場定位分析（基於現有資訊）
  • 供應商情況（基於現有資訊）
  • 策略規劃

第11章：公司簡介

  • 主要公司的市佔率分析
  • 公司簡介
    • Thermo Fisher ScientificInc
    • F. Hoffmann-La Roche Ltd
    • Danaher Corporation
    • Abbott Laboratories
    • Hologic Inc
    • PerkinElmerInc
    • BioMerieux SA
    • Quidel Corporation
    • Luminex Corporation
    • Laboratory Corporation Of America Holdings
    • Quest Diagnostics
    • Altona Diagnostics GmbH
    • Veredus Laboratories
    • 1drop Inc
    • ADT BIoTech Sdn Bhd
簡介目錄
Product Code: VMR11212426

The global COVID-19 diagnostic market size is expected to reach USD 1.78 Billion in 2034 from USD 13.12 Billion in 2025, growing at a CAGR of -19.88% during 2026-2034.The global COVID-19 diagnostic market expanded rapidly during the pandemic as healthcare systems required fast and accurate testing methods to detect infections. Diagnostic technologies such as PCR tests, antigen tests, and antibody tests became essential tools for monitoring the spread of the virus. Governments and healthcare organizations invested heavily in large-scale testing programs, which significantly boosted the demand for COVID-19 diagnostic solutions across hospitals, laboratories, and testing centers.

One of the major drivers of the market is the need for early and reliable detection of infectious diseases. Rapid diagnostic kits and point-of-care testing have improved the speed of diagnosis, helping healthcare professionals respond quickly to outbreaks. Increased investments in diagnostic infrastructure and biotechnology research have also strengthened the development of advanced testing technologies.

Looking ahead, the COVID-19 diagnostic market is expected to evolve with improved molecular testing platforms and multi-disease diagnostic tools. Lessons learned from the pandemic have encouraged governments to strengthen diagnostic preparedness for future outbreaks. Continued innovation in rapid testing and laboratory automation will likely support sustained growth in the global diagnostics industry.

Our reports are carefully developed to deliver comprehensive and actionable insights across a wide range of industries and markets. Each report includes several essential components designed to provide a complete understanding of the market environment:

Market Overview: This section provides a clear introduction to the market, including key definitions, classifications, and an overview of the current industry landscape.

Market Dynamics: A detailed evaluation of the primary drivers, restraints, opportunities, and challenges shaping market growth. It covers factors such as technological developments, regulatory frameworks, and evolving industry trends.

Segmentation Analysis: A structured breakdown of the market into key segments based on product type, application, end-user, and geographic region. This section highlights the performance, growth potential, and contribution of each segment.

Competitive Landscape: An in-depth assessment of leading market participants, including their market positioning, product portfolios, strategic initiatives, and financial performance. It provides valuable insights into competitive dynamics and the strategies adopted by key players.

Market Forecast: Data-driven projections of market size and growth patterns over a defined forecast period. This section incorporates historical trends, current market conditions, and quantitative analysis to illustrate expected future developments.

Regional Analysis: A comprehensive review of market performance across major geographic regions, identifying high-growth areas and regional trends to better understand localized market opportunities.

Emerging Trends and Opportunities: Identification of significant market trends, technological advancements, and new investment opportunities. This section highlights potential growth areas and future industry developments.

Customization Options: We offer flexible customization services to tailor reports according to specific client requirements. This may include additional segmentation, country-level analysis, competitor profiling, customized data points, or focused insights on particular market segments to better support strategic decision-making.

MARKET SEGMENTATION

By Product & Service

  • Instruments
  • Reagents & Kits
  • Services

By Sample Type

  • Nasopharyngeal (NP) swabs
  • Oropharyngeal (OP) swabs
  • Nasal swabs
  • Blood
  • Others

By Test Type

  • Molecular (PCR) Testing
  • Antigen-based Testing
  • Antibody (Serology) Testing
  • Others

By Mode

  • Point-of-Care (PoC)
  • Non-Point-of-Care (Non-PoC)

By End-Use

  • Laboratories
  • Hospitals
  • Diagnostic Centers and Clinics
  • Others

COMPANIES PROFILED

  • Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche Ltd., Danaher Corporation, Abbott Laboratories, Hologic Inc., PerkinElmer, Inc., bioMerieux SA, Quidel Corporation, Luminex Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics, Altona Diagnostics GmbH, Veredus Laboratories, 1drop Inc., ADT Biotech Sdn Bhd

TABLE OF CONTENTS

Chapter 1. PREFACE

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1 Information Analysis
    • 1.3.2 Market Formulation & Data Visualization
    • 1.3.3 Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

  • 2.1. Market Snapshot
  • 2.2. Segmental Outlook
  • 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

  • 3.1. Market Lineage Outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Value Chain Analysis
  • 3.4. Regulatory Framework
    • 3.4.1 Standards & Compliance
    • 3.4.2 Regulatory Impact Analysis
  • 3.5. Market Dynamics
    • 3.5.1 Market Drivers
    • 3.5.2 Market Restraints
    • 3.5.3 Market Opportunities
    • 3.5.4 Market Challenges
  • 3.6. Porter's Five Forces Analysis
  • 3.7. PESTLE Analysis

Chapter 4. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY PRODUCT & SERVICE 2022-2034 (USD MN)

  • 4.1. Market Analysis, Insights and Forecast Product & Service
  • 4.2. Instruments Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.3. Reagents & Kits Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 4.4. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY SAMPLE TYPE 2022-2034 (USD MN)

  • 5.1. Market Analysis, Insights and Forecast Sample Type
  • 5.2. Nasopharyngeal (NP) swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.3. Oropharyngeal (OP) swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.4. Nasal swabs Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.5. Blood Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY TEST TYPE 2022-2034 (USD MN)

  • 6.1. Market Analysis, Insights and Forecast Test Type
  • 6.2. Molecular (PCR) Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.3. Antigen-based Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.4. Antibody (Serology) Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY MODE 2022-2034 (USD MN)

  • 7.1. Market Analysis, Insights and Forecast Mode
  • 7.2. Point-of-Care (PoC) Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 7.3. Non-Point-of-Care (Non-PoC) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY END-USE 2022-2034 (USD MN)

  • 8.1. Market Analysis, Insights and Forecast End-use
  • 8.2. Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.3. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.4. Diagnostic Centers and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
  • 8.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL COVID-19 DIAGNOSTIC MARKET: BY REGION 2022-2034 (USD MN)

  • 9.1. Regional Outlook
  • 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.2.1 By Product & Service
    • 9.2.2 By Sample Type
    • 9.2.3 By Test Type
    • 9.2.4 By Mode
    • 9.2.5 By End-use
    • 9.2.6 United States
    • 9.2.7 Canada
    • 9.2.8 Mexico
  • 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.3.1 By Product & Service
    • 9.3.2 By Sample Type
    • 9.3.3 By Test Type
    • 9.3.4 By Mode
    • 9.3.5 By End-use
    • 9.3.6 United Kingdom
    • 9.3.7 France
    • 9.3.8 Germany
    • 9.3.9 Italy
    • 9.3.10 Russia
    • 9.3.11 Rest Of Europe
  • 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.4.1 By Product & Service
    • 9.4.2 By Sample Type
    • 9.4.3 By Test Type
    • 9.4.4 By Mode
    • 9.4.5 By End-use
    • 9.4.6 India
    • 9.4.7 Japan
    • 9.4.8 South Korea
    • 9.4.9 Australia
    • 9.4.10 South East Asia
    • 9.4.11 Rest Of Asia Pacific
  • 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.5.1 By Product & Service
    • 9.5.2 By Sample Type
    • 9.5.3 By Test Type
    • 9.5.4 By Mode
    • 9.5.5 By End-use
    • 9.5.6 Brazil
    • 9.5.7 Argentina
    • 9.5.8 Peru
    • 9.5.9 Chile
    • 9.5.10 Rest of Latin America
  • 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
    • 9.6.1 By Product & Service
    • 9.6.2 By Sample Type
    • 9.6.3 By Test Type
    • 9.6.4 By Mode
    • 9.6.5 By End-use
    • 9.6.6 Saudi Arabia
    • 9.6.7 UAE
    • 9.6.8 Israel
    • 9.6.9 South Africa
    • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

  • 10.1. Recent Developments
  • 10.2. Company Categorization
  • 10.3. Supply Chain & Channel Partners (based on availability)
  • 10.4. Market Share & Positioning Analysis (based on availability)
  • 10.5. Vendor Landscape (based on availability)
  • 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL COVID-19 DIAGNOSTIC INDUSTRY

  • 11.1. Top Companies Market Share Analysis
  • 11.2. Company Profiles
    • 11.2.1 Thermo Fisher ScientificInc
    • 11.2.2 F. Hoffmann-La Roche Ltd
    • 11.2.3 Danaher Corporation
    • 11.2.4 Abbott Laboratories
    • 11.2.5 Hologic Inc
    • 11.2.6 PerkinElmerInc
    • 11.2.7 BioMerieux SA
    • 11.2.8 Quidel Corporation
    • 11.2.9 Luminex Corporation
    • 11.2.10 Laboratory Corporation Of America Holdings
    • 11.2.11 Quest Diagnostics
    • 11.2.12 Altona Diagnostics GmbH
    • 11.2.13 Veredus Laboratories
    • 11.2.14 1drop Inc
    • 11.2.15 ADT Biotech Sdn Bhd